| Utestående aktier | 56,935,279 shares |
| Insideraktier | 20 186 165 shares |
| Insynsägande | 35,45 % |
| Totalt antal insynspersoner | 32 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5815 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Black Diamond Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Biotech Ag Bb
10% Owner -
|
4 694 113 | 2 733 547 | |
|
Growth N V Biotech
10% Owner -
|
2 733 547 | 2 733 547 | |
| Ali Behbahani Director - [D] | 4 530 198 | 4 530 198 | |
|
Bradley J PhD Bolzon
Director, 10% Owner -
[D]
|
21 851 | 21 851 | |
| Elizabeth Buck CHIEF SCIENTIFIC OFFICER - [O] | 170 192 | 170 192 | |
| Shannon Campbell Director - [D] | 8 865 | 8 865 | |
|
Management Co Deerfield
10% Owner -
|
778 790 | 778 790 | |
|
Deerfield Partners, L.p.
10% Owner -
|
778 790 | 778 790 | |
| Wendy L Dixon Director - [D] | 38 054 | 38 054 | |
|
Deerfield Mgmt L.P.
10% Owner -
|
778 790 | 778 790 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Kapil Dhingra Director - [D] | 10 000 | 10 000 | |
| Epstein David M. SEE REMARKS, Director - [D] [O] | 936 569 | 936 569 | |
|
James E Flynn
10% Owner -
|
778 790 | 778 790 | |
| Rachel Humphrey Chief Medical Officer - [O] | 10 000 | 10 000 | |
| Brent Hatzis-Schoch SEE REMARKS - [O] | 83 400 | 83 400 | |
| Robert Alexander Ingram - | 42 854 | 42 854 | |
| Erika Jones SEE REMARKS - [O] | 85 150 | 85 150 | |
| Thomas Leggett Chief Financial Officer - [O] | 0 | 0 | |
| Alexander Mayweg Director - [D] | 32 494 | 32 494 | |
| Garry E Menzel Director - [D] | 51 825 | 51 825 | |
| Fang Ni SEE REMARKS - [O] | 125 389 | 125 389 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Ra Capital Management, Llc Director - [D] | 3 525 754 | 3 525 754 | |
| Prakash Raman Director - [D] | 26 362 | 26 362 | |
| Roberts Christopher D. Chief Scientific Officer - [O] | 3 200 | 3 200 | |
| Shah Rajeev M. Director - [D] | 0 | 3 525 754 | |
| Velleca Mark A. PRESIDENT & CEO, Director - [D] [O] | 121 522 | 121 522 | |
|
Versant Vantage I, L.P.
10% Owner -
|
0 | 6 206 964 | |
|
Versant Venture Capital VI, L.P.
10% Owner -
|
6 206 964 | 6 206 964 | |
|
Versant Voyageurs I Parallel, L.P.
10% Owner -
|
0 | 6 206 964 | |
|
Versant Voyageurs I, L.P.
10% Owner -
|
0 | 6 206 964 | |
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner -
|
568 185 | 568 185 | |
| Sergey Yurasov CHIEF MEDICAL OFFICER - [O] | 75 000 | 75 000 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i BDTX / Black Diamond Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i BDTX / Black Diamond Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-22 | 2025-09-19 | 4 | Behbahani Ali | BDTX | Common Stock | D | 3,3500 | 4 291 | 14 | 81 441 | ||||
| 2025-09-22 | 2025-09-19 | 4 | Raman Prakash | BDTX | Common Stock | D | 3,3500 | 3 843 | 13 | 26 362 | ||||
| 2025-06-20 | 2025-06-20 | 4 | Behbahani Ali | BDTX | Common Stock | D | 2,3300 | 6 170 | 14 | 77 150 | ||||
| 2025-06-20 | 2025-06-20 | 4 | Raman Prakash | BDTX | Common Stock | D | 2,3300 | 5 526 | 13 | 22 519 | ||||
| 2025-03-21 | 2025-03-21 | 4 | Behbahani Ali | BDTX | Common Stock | D | 1,8800 | 7 646 | 14 | 70 980 | ||||
| 2025-03-21 | 2025-03-21 | 4 | Raman Prakash | BDTX | Common Stock | D | 1,8800 | 6 848 | 13 | 16 993 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,1169 | −500 000 | −1 058 | 2 733 547 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 1,9532 | −584 292 | −1 141 | 3 233 547 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,0929 | −400 000 | −837 | 3 817 839 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,0004 | −2 000 000 | −4 001 | 4 217 839 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,3081 | −1 000 000 | −2 308 | 6 217 839 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 1,9430 | −300 000 | −583 | 7 217 839 | ||||
| 2025-03-20 | 2025-03-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,0691 | −1 000 000 | −2 069 | 7 517 839 | ||||
| 2025-01-31 | 2025-01-30 | 4 | Yurasov Sergey | BDTX | Common Stock | D | 75 000 | 75 000 | ||||||
| 2025-01-31 | 2025-01-30 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 75 000 | 121 522 | ||||||
| 2025-01-31 | 2025-01-30 | 4 | Jones Erika | BDTX | Common Stock | D | 75 000 | 85 150 | ||||||
| 2025-01-31 | 2025-01-30 | 4 | Buck Elizabeth | BDTX | Common Stock | D | 75 000 | 170 192 | ||||||
| 2025-01-31 | 2025-01-30 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 75 000 | 83 400 | ||||||
| 2024-12-16 | 2024-12-13 | 4 | Behbahani Ali | BDTX | Common Stock | D | 2,5000 | 5 750 | 14 | 63 334 | ||||
| 2024-12-16 | 2024-12-13 | 4 | Campbell Shannon | BDTX | Common Stock | D | 2,5000 | 4 500 | 11 | 8 865 | ||||
| 2024-12-16 | 2024-12-13 | 4 | Raman Prakash | BDTX | Common Stock | D | 2,5000 | 5 150 | 13 | 10 145 | ||||
| 2024-09-20 | 2024-09-20 | 4 | Behbahani Ali | BDTX | Common Stock | D | 4,7800 | 3 007 | 14 | 57 584 | ||||
| 2024-09-20 | 2024-09-20 | 4 | Campbell Shannon | BDTX | Common Stock | D | 4,7800 | 2 354 | 11 | 4 365 | ||||
| 2024-09-20 | 2024-09-20 | 4 | Raman Prakash | BDTX | Common Stock | D | 4,7800 | 2 694 | 13 | 4 995 | ||||
| 2024-08-30 | 2024-08-28 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 6,3202 | −221 600 | −1 401 | 3 726 341 | ||||
| 2024-06-21 | 2024-06-21 | 4 | Behbahani Ali | BDTX | Common Stock | D | 4,9800 | 2 887 | 14 | 54 577 | ||||
| 2024-06-21 | 2024-06-21 | 4 | Raman Prakash | BDTX | Common Stock | D | 4,9800 | 2 301 | 11 | 2 301 | ||||
| 2024-06-21 | 2024-06-21 | 4 | Campbell Shannon | BDTX | Common Stock | D | 4,9800 | 2 011 | 10 | 2 011 | ||||
| 2024-04-03 | 2024-03-15 | 4 | Behbahani Ali | BDTX | Common Stock | D | 4,5400 | 3 166 | 14 | 51 690 | ||||
| 2024-04-03 | 2024-03-15 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 4,5400 | 3 253 | 15 | 38 054 | ||||
| 2023-12-15 | 2023-12-15 | 4 | Behbahani Ali | BDTX | Common Stock | D | 2,7300 | 4 455 | 12 | 48 524 | ||||
| 2023-12-15 | 2023-12-15 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 2,7300 | 4 043 | 11 | 34 801 | ||||
| 2023-10-19 | 2023-10-17 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,3352 | 400 000 | 934 | 8 517 839 | ||||
| 2023-09-18 | 2023-09-15 | 4 | Behbahani Ali | BDTX | Common Stock | D | 3,6000 | 3 299 | 12 | 44 069 | ||||
| 2023-09-18 | 2023-09-15 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 3,6000 | 2 986 | 11 | 30 758 | ||||
| 2023-09-18 | 2023-09-15 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 3,6000 | 5 208 | 19 | 46 522 | ||||
| 2023-07-07 | 2023-07-05 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | BDTX | Common Stock | I | 5,0000 | 935 850 | 4 679 | 3 213 828 | ||||
| 2023-07-06 | 2023-07-05 | 4 | Behbahani Ali See Note 2 | BDTX | Common Stock | I | 5,0000 | 1 000 000 | 5 000 | 4 448 757 | ||||
| 2023-07-03 | 2023-06-30 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 5,0000 | 1 000 000 | 5 000 | 8 117 839 | ||||
| 2023-06-29 | 2023-06-27 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 5,4914 | 1 740 000 | 9 555 | 7 117 839 | ||||
| 2023-06-28 | 2023-06-27 | 4 | Epstein David M. | BDTX | Common Stock | D | 6,7000 | −25 000 | −168 | 671 423 | ||||
| 2023-06-16 | 2023-06-16 | 4 | Behbahani Ali | BDTX | Common Stock | D | 2,1000 | 5 655 | 12 | 40 770 | ||||
| 2023-06-16 | 2023-06-16 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 2,1000 | 5 119 | 11 | 27 772 | ||||
| 2023-06-16 | 2023-06-16 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 2,1000 | 8 929 | 19 | 41 314 | ||||
| 2023-03-20 | 2023-03-16 | 4 | Behbahani Ali | BDTX | Common Stock | D | 1,6700 | 7 111 | 12 | 35 115 | ||||
| 2023-03-20 | 2023-03-16 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 1,6700 | 6 437 | 11 | 22 653 | ||||
| 2023-03-20 | 2023-03-16 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 1,6700 | 11 228 | 19 | 32 385 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Jones Erika | BDTX | Common Stock | D | 5 075 | 10 150 | ||||||
| 2022-12-23 | 2022-12-22 | 4 | Ni Fang | BDTX | Common Stock | D | 1,2814 | 36 363 | 47 | 125 389 | ||||
| 2022-12-23 | 2022-12-21 | 4 | Ni Fang | BDTX | Common Stock | D | 1,2885 | 20 000 | 26 | 89 026 | ||||
| 2022-12-19 | 2022-12-16 | 4 | Behbahani Ali | BDTX | Common Stock | D | 1,5000 | 7 917 | 12 | 28 004 | ||||
| 2022-12-19 | 2022-12-16 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 1,5000 | 8 424 | 13 | 21 157 | ||||
| 2022-12-19 | 2022-12-16 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 1,5000 | 9 375 | 14 | 42 854 | ||||
| 2022-12-19 | 2022-12-16 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 1,5000 | 7 167 | 11 | 16 216 | ||||
| 2022-11-02 | 2022-10-31 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,2536 | 99 801 | 225 | 5 377 839 | ||||
| 2022-10-31 | 2022-10-28 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,1793 | 172 974 | 377 | 5 278 038 | ||||
| 2022-10-31 | 2022-10-27 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 1,8741 | 191 678 | 359 | 5 105 064 | ||||
| 2022-10-25 | 2022-10-21 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 1,5111 | 87 850 | 133 | 4 913 386 | ||||
| 2022-10-21 | 2022-10-20 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 1,4208 | 53 734 | 76 | 4 825 536 | ||||
| 2022-10-21 | 2022-10-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 1,3229 | 77 689 | 103 | 4 771 802 | ||||
| 2022-09-19 | 2022-09-16 | 4 | Behbahani Ali | BDTX | Common Stock | D | 2,6200 | 4 532 | 12 | 20 087 | ||||
| 2022-09-19 | 2022-09-16 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 2,6200 | 4 103 | 11 | 9 049 | ||||
| 2022-09-19 | 2022-09-16 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 2,6200 | 4 294 | 11 | 12 733 | ||||
| 2022-09-19 | 2022-09-16 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 2,6200 | 6 584 | 17 | 33 479 | ||||
| 2022-06-30 | 2022-06-17 | 4/A | DIXON WENDY L | BDTX | Common Stock | D | 2,0300 | 4 946 | 10 | 4 946 | ||||
| 2022-06-30 | 2022-06-29 | 4 | Ni Fang | BDTX | Common Stock | D | 2,4407 | 25 000 | 61 | 69 026 | ||||
| 2022-06-17 | 2022-06-17 | 4 | DIXON WENDY L | BDTX | Common Stock | D | 2,0300 | 4 060 | 8 | 4 060 | ||||
| 2022-06-17 | 2022-06-17 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 2,0300 | 8 498 | 17 | 26 895 | ||||
| 2022-06-17 | 2022-06-17 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 2,0300 | 5 542 | 11 | 8 439 | ||||
| 2022-06-17 | 2022-06-17 | 4 | Behbahani Ali | BDTX | Common Stock | D | 2,0300 | 5 850 | 12 | 15 555 | ||||
| 2022-04-29 | 2022-04-28 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,5727 | 255 711 | 658 | 4 694 113 | ||||
| 2022-04-29 | 2022-04-27 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 2,6632 | 150 000 | 399 | 4 438 402 | ||||
| 2022-04-20 | 2022-04-19 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 3,2443 | 150 000 | 487 | 4 288 402 | ||||
| 2022-04-20 | 2022-04-18 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 3,2929 | 150 000 | 494 | 4 138 402 | ||||
| 2022-04-14 | 2022-04-13 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 3,5709 | 102 556 | 366 | 3 988 402 | ||||
| 2022-04-14 | 2022-04-12 | 4 | BIOTECH GROWTH N V | BDTX | Common Stock | D | 3,4240 | 150 000 | 514 | 3 885 846 | ||||
| 2022-04-13 | 3 | BB BIOTECH AG | BDTX | Common Stock | D | 3 735 846 | ||||||||
| 2022-04-07 | 2022-04-06 | 4 | DIXON WENDY L | BDTX | Stock Option (Right to Buy) | D | 3,04 | 30 000 | 30 000 | |||||
| 2022-03-18 | 2022-03-18 | 4 | Behbahani Ali | BDTX | Common Stock | D | 3,0200 | 4 346 | 13 | 9 705 | ||||
| 2022-03-18 | 2022-03-18 | 4 | Velleca Mark A. | BDTX | Common Stock | D | 3,0200 | 2 897 | 9 | 2 897 | ||||
| 2022-03-18 | 2022-03-18 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 3,0200 | 5 795 | 18 | 18 397 | ||||
| 2022-02-17 | 2022-02-15 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 3,79 | 300 000 | 300 000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Jones Erika | BDTX | Stock Option (Right to Buy) | D | 3,79 | 20 300 | 20 300 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Jones Erika | BDTX | Common Stock | D | 5 075 | 5 075 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Buck Elizabeth | BDTX | Stock Option (Right to Buy) | D | 3,79 | 90 000 | 90 000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Ni Fang | BDTX | Stock Option (Right to Buy) | D | 3,79 | 100 000 | 100 000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,79 | 90 000 | 90 000 | |||||
| 2021-12-17 | 2021-12-17 | 4 | Behbahani Ali | BDTX | Common Stock | D | 5,3100 | 2 472 | 13 | 5 359 | ||||
| 2021-12-17 | 2021-12-17 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 5,3100 | 3 296 | 18 | 12 602 | ||||
| 2021-11-29 | 3 | Ni Fang | BDTX | Common Stock | D | 44 026 | ||||||||
| 2021-09-23 | 2021-09-17 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 9,9000 | 1 869 | 19 | 9 306 | ||||
| 2021-09-23 | 2021-09-17 | 4 | Behbahani Ali | BDTX | Common Stock | D | 9,9000 | 1 326 | 13 | 2 887 | ||||
| 2021-09-17 | 3 | Buck Elizabeth | BDTX | Common Stock | D | 95 192 | ||||||||
| 2021-08-11 | 2021-08-09 | 4 | Velleca Mark A. | BDTX | Stock Option (Right to Buy) | D | 9,85 | 30 000 | 30 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Behbahani Ali | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Behbahani Ali | BDTX | Common Stock | D | 12,9500 | 1 014 | 13 | 1 561 | ||||
| 2021-06-22 | 2021-06-18 | 4 | Shah Rajeev M. | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Menzel Garry E | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 12,9500 | 1 255 | 16 | 7 437 | ||||
| 2021-06-22 | 2021-06-18 | 4 | Kulkarni Samarth | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Mayweg Alexander | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Dhingra Kapil | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Bolzon Bradley J PhD | BDTX | Stock Option (Right to Buy) | D | 12,55 | 15 000 | 15 000 | |||||
| 2021-05-21 | 2021-05-20 | 4 | Shah Rajeev M. | BDTX | Common Stock | D | 24,0100 | −443 | −11 | 0 | ||||
| 2021-05-13 | 2021-05-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 160 474 | |||||
| 2021-05-13 | 2021-05-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 28,2044 | −351 | −10 | 8 400 | ||||
| 2021-05-13 | 2021-05-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 27,9018 | −2 566 | −72 | 8 751 | ||||
| 2021-05-13 | 2021-05-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 26,1060 | −1 161 | −30 | 11 317 | ||||
| 2021-05-13 | 2021-05-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 12 478 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 163 609 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 26,6409 | −2 500 | −67 | 3 200 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 5 700 | ||||
| 2021-04-23 | 2021-04-20 | 4 | Kulkarni Samarth | BDTX | Stock Option (Right to Buy) | D | 24,33 | 14 921 | 14 921 | |||||
| 2021-04-23 | 2021-04-20 | 4 | Menzel Garry E | BDTX | Stock Option (Right to Buy) | D | 24,33 | 14 921 | 14 921 | |||||
| 2021-04-13 | 2021-04-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −179 915 | 164 552 | |||||
| 2021-04-13 | 2021-04-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 25,0000 | −4 078 | −102 | 8 400 | ||||
| 2021-04-13 | 2021-04-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 12 478 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 166 109 | |||||
| 2021-04-07 | 2021-04-05 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 25,5390 | −2 500 | −64 | 3 200 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 5 700 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 24,2600 | 353 814 | 8 584 | 2 277 978 | ||||
| 2021-03-22 | 2021-03-18 | 4 | Behbahani Ali | BDTX | Common Stock | D | 24,0100 | 547 | 13 | 547 | ||||
| 2021-03-22 | 2021-03-18 | 4 | Shah Rajeev M. | BDTX | Common Stock | D | 24,0100 | 443 | 11 | 443 | ||||
| 2021-03-22 | 2021-03-18 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 24,0100 | 677 | 16 | 6 182 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 168 630 | |||||
| 2021-03-16 | 2021-03-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 26,3593 | −4 078 | −107 | 8 400 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 12 478 | ||||
| 2021-03-04 | 2021-03-03 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 168 609 | |||||
| 2021-03-04 | 2021-03-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 26,5651 | −884 | −23 | 3 200 | ||||
| 2021-03-04 | 2021-03-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 25,8529 | −1 616 | −42 | 4 084 | ||||
| 2021-03-04 | 2021-03-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 5 700 | ||||
| 2021-02-19 | 2021-02-17 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 28,69 | 75 000 | 75 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 28,69 | 75 000 | 75 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | HUMPHREY RACHEL | BDTX | Stock Option (Right to Buy) | D | 28,69 | 60 000 | 60 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 28,69 | 75 000 | 75 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 28,69 | 225 000 | 225 000 | |||||
| 2021-02-12 | 2021-02-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 172 708 | |||||
| 2021-02-12 | 2021-02-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 27,6619 | −307 | −8 | 8 400 | ||||
| 2021-02-12 | 2021-02-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 27,1898 | −3 771 | −103 | 8 707 | ||||
| 2021-02-12 | 2021-02-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 12 478 | ||||
| 2021-02-04 | 2021-02-03 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 171 109 | |||||
| 2021-02-04 | 2021-02-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 25,3500 | −2 500 | −63 | 3 200 | ||||
| 2021-02-04 | 2021-02-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 5 700 | ||||
| 2021-01-22 | 2021-01-19 | 4 | Dhingra Kapil | BDTX | Stock Option (Right to Buy) | D | 27,45 | 29 842 | 29 842 | |||||
| 2021-01-22 | 3 | Dhingra Kapil | BDTX | Common Stock | D | 10 000 | ||||||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 10,86 | −7 500 | 71 251 | |||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 176 786 | |||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 35,9999 | −7 511 | −270 | 8 400 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 34,1250 | −100 | −3 | 15 911 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 32,4974 | −103 | −3 | 16 011 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 31,9077 | −147 | −5 | 16 114 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 30,5043 | −1 669 | −51 | 16 261 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 29,9236 | −2 048 | −61 | 17 930 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 10,8600 | 7 500 | 81 | 19 978 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 12 478 | ||||
| 2021-01-11 | 2021-01-08 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 10,86 | −3 000 | 218 171 | |||||
| 2021-01-11 | 2021-01-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 33,9400 | −3 000 | −102 | 0 | ||||
| 2021-01-11 | 2021-01-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 10,8600 | 3 000 | 33 | 3 000 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 173 609 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 31,7775 | −537 | −17 | 3 200 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 31,3093 | −1 963 | −61 | 3 737 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 5 700 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 6,42 | −3 000 | 230 116 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Epstein David M. | BDTX | Common Stock | D | 31,7989 | −2 015 | −64 | 696 423 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Epstein David M. | BDTX | Common Stock | D | 30,9895 | −9 985 | −309 | 698 438 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Epstein David M. | BDTX | Common Stock | D | 6,4200 | 3 000 | 19 | 708 423 | ||||
| 2020-12-29 | 2020-12-28 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −5 400 | 180 864 | |||||
| 2020-12-29 | 2020-12-28 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 5 400 | 17 | 8 400 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 186 264 | |||||
| 2020-12-16 | 2020-12-14 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 34,9491 | −4 078 | −143 | 3 000 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 7 078 | ||||
| 2020-12-16 | 2020-12-15 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −3 200 | 176 109 | |||||
| 2020-12-16 | 2020-12-15 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 3 200 | 35 | 3 200 | ||||
| 2020-12-16 | 2020-12-15 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 34,2900 | 505 | 17 | 5 505 | ||||
| 2020-12-16 | 2020-12-15 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 6,42 | −2 500 | 233 116 | |||||
| 2020-12-16 | 2020-12-15 | 4 | Epstein David M. | BDTX | Common Stock | D | 6,4200 | 2 500 | 16 | 705 423 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −307 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 307 | 307 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −310 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 310 | 310 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −20 784 | 822 140 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 11 | 21 851 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −307 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 307 | 307 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −310 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 310 | 310 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −20 784 | 822 140 | ||||||
| 2020-12-10 | 2020-12-08 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 10,86 | −3 000 | 221 171 | |||||
| 2020-12-10 | 2020-12-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 34,0514 | −1 941 | −66 | 0 | ||||
| 2020-12-10 | 2020-12-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 33,2701 | −1 059 | −35 | 1 941 | ||||
| 2020-12-10 | 2020-12-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 10,8600 | 3 000 | 33 | 3 000 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 179 309 | |||||
| 2020-12-04 | 2020-12-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 32,4221 | −2 500 | −81 | 0 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 2 500 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 6,42 | −3 000 | 235 616 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Epstein David M. | BDTX | Common Stock | D | 33,4455 | −1 077 | −36 | 702 923 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Epstein David M. | BDTX | Common Stock | D | 32,6424 | −10 923 | −357 | 704 000 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Epstein David M. | BDTX | Common Stock | D | 6,4200 | 3 000 | 19 | 714 923 | ||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −463 | 0 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 463 | 463 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −467 | 0 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 467 | 467 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −31 175 | 842 924 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 34,1646 | −200 | −7 | 874 099 | ||||
| 2020-12-01 | 2020-11-30 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,1286 | −10 193 | −338 | 874 299 | ||||
| 2020-12-01 | 2020-11-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −6 797 | 0 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 6 797 | 6 797 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −7 880 | 0 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 7 880 | 7 880 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | −394 000 | 3 947 941 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 15 | 21 840 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −463 | 0 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 463 | 463 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −467 | 0 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 467 | 467 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −31 175 | 842 924 | ||||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,1646 | −200 | −7 | 874 099 | ||||
| 2020-12-01 | 2020-11-30 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1286 | −10 193 | −338 | 874 299 | ||||
| 2020-12-01 | 2020-11-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 2 256 | 21 825 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −6 797 | 0 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 6 797 | 6 797 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −7 880 | 0 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 7 880 | 7 880 | ||||||
| 2020-12-01 | 2020-11-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −394 000 | 3 947 941 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −3 316 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 2 488 | 3 316 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −46 121 | 380 942 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 828 | 828 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −154 671 | 1 277 541 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −1 258 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 258 | 1 258 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −1 269 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 269 | 1 269 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −84 462 | 884 492 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −8 223 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 8 223 | 8 223 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −9 533 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 9 533 | 9 533 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | −476 659 | 4 341 941 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 164 | 19 569 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −3 316 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 2 488 | 3 316 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −46 121 | 380 942 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 828 | 828 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −154 671 | 1 277 541 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 43 | 18 405 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −1 258 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 258 | 1 258 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −1 269 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 269 | 1 269 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −84 462 | 884 492 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 2 728 | 18 362 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −8 223 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 8 223 | 8 223 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −9 533 | 0 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 9 533 | 9 533 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −476 659 | 4 341 941 | ||||||
| 2020-11-23 | 2020-11-19 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0100 | −114 854 | −3 791 | 4 818 600 | ||||
| 2020-11-23 | 2020-11-19 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0100 | −15 163 | −501 | 968 954 | ||||
| 2020-11-23 | 2020-11-19 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0100 | −114 854 | −3 791 | 4 818 600 | ||||
| 2020-11-23 | 2020-11-19 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0100 | −15 163 | −501 | 968 954 | ||||
| 2020-11-19 | 2020-11-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0938 | −473 | −16 | 4 933 454 | ||||
| 2020-11-19 | 2020-11-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0938 | −63 | −2 | 984 117 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0498 | −3 705 | −122 | 4 933 927 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0498 | −489 | −16 | 984 180 | ||||
| 2020-11-19 | 2020-11-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0938 | −473 | −16 | 4 933 454 | ||||
| 2020-11-19 | 2020-11-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0938 | −63 | −2 | 984 117 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0498 | −3 705 | −122 | 4 933 927 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0498 | −489 | −16 | 984 180 | ||||
| 2020-11-17 | 2020-11-16 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0125 | −177 | −6 | 4 937 632 | ||||
| 2020-11-17 | 2020-11-16 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0125 | −23 | −1 | 984 669 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 34,5309 | −1 502 | −52 | 4 937 809 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,3149 | −2 473 | −82 | 4 939 311 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 34,5309 | −198 | −7 | 984 692 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,3149 | −327 | −11 | 984 890 | ||||
| 2020-11-17 | 2020-11-16 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0125 | −177 | −6 | 4 937 632 | ||||
| 2020-11-17 | 2020-11-16 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0125 | −23 | −1 | 984 669 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,5309 | −1 502 | −52 | 4 937 809 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,3149 | −2 473 | −82 | 4 939 311 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,5309 | −198 | −7 | 984 692 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,3149 | −327 | −11 | 984 890 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 190 342 | |||||
| 2020-11-13 | 2020-11-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 35,0087 | −250 | −9 | 3 000 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 34,2404 | −2 261 | −77 | 3 250 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 33,4632 | −1 567 | −52 | 5 511 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 7 078 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 35,1488 | −353 | −12 | 4 941 784 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,3928 | −9 450 | −325 | 4 942 137 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,4774 | −3 976 | −133 | 4 951 587 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 35,1488 | −47 | −2 | 985 217 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,3928 | −1 248 | −43 | 985 264 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,4774 | −524 | −18 | 986 512 | ||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 502 | 15 634 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −4 282 | 0 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 3 211 | 4 282 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −59 534 | 427 063 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 071 | 1 071 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −199 652 | 1 432 212 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 3 954 | 14 132 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −11 918 | 0 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 11 918 | 11 918 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −13 816 | 0 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 13 816 | 13 816 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −690 814 | 4 955 563 | ||||||
| 2020-11-13 | 2020-11-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 35,1488 | −353 | −12 | 4 941 784 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 34,3928 | −9 450 | −325 | 4 942 137 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,4774 | −3 976 | −133 | 4 951 587 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 35,1488 | −47 | −2 | 985 217 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 34,3928 | −1 248 | −43 | 985 264 | ||||
| 2020-11-13 | 2020-11-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,4774 | −524 | −18 | 986 512 | ||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −4 282 | 0 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 3 211 | 4 282 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −59 534 | 427 063 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 071 | 1 071 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −199 652 | 1 432 212 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −11 918 | 0 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 11 918 | 11 918 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −13 816 | 0 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 13 816 | 13 816 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | −690 814 | 4 955 563 | ||||||
| 2020-11-13 | 2020-11-11 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −5 000 | 181 809 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 34,9000 | −5 000 | −174 | 0 | ||||
| 2020-11-13 | 2020-11-11 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 5 000 | 54 | 5 000 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 10,86 | −3 000 | 224 171 | |||||
| 2020-11-12 | 2020-11-09 | 4 | Leggett Thomas | BDTX | Common Stock | D | 32,9639 | −3 000 | −99 | 0 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Leggett Thomas | BDTX | Common Stock | D | 10,8600 | 3 000 | 33 | 3 000 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 34,9372 | −9 027 | −315 | 5 646 377 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,8596 | −2 119 | −72 | 5 655 404 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 34,9372 | −1 191 | −42 | 987 036 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,8596 | −280 | −9 | 988 227 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 34,1438 | −12 433 | −425 | 5 657 523 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,4778 | −11 388 | −381 | 5 669 956 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 34,1438 | −1 642 | −56 | 988 507 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,4778 | −1 503 | −50 | 990 149 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,9372 | −9 027 | −315 | 5 646 377 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,8596 | −2 119 | −72 | 5 655 404 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,9372 | −1 191 | −42 | 987 036 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,8596 | −280 | −9 | 988 227 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,1438 | −12 433 | −425 | 5 657 523 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,4778 | −11 388 | −381 | 5 669 956 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 34,1438 | −1 642 | −56 | 988 507 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,4778 | −1 503 | −50 | 990 149 | ||||
| 2020-11-10 | 2020-11-09 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0556 | −5 565 | −184 | 5 681 344 | ||||
| 2020-11-10 | 2020-11-09 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0556 | −735 | −24 | 991 652 | ||||
| 2020-11-10 | 2020-11-06 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1285 | −2 738 | −91 | 5 686 909 | ||||
| 2020-11-10 | 2020-11-06 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1285 | −362 | −12 | 992 387 | ||||
| 2020-11-10 | 2020-11-09 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0556 | −5 565 | −184 | 5 681 344 | ||||
| 2020-11-10 | 2020-11-09 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0556 | −735 | −24 | 991 652 | ||||
| 2020-11-10 | 2020-11-06 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,1285 | −2 738 | −91 | 5 686 909 | ||||
| 2020-11-10 | 2020-11-06 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,1285 | −362 | −12 | 992 387 | ||||
| 2020-11-06 | 2020-11-05 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1473 | −7 816 | −259 | 5 689 647 | ||||
| 2020-11-06 | 2020-11-05 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1473 | −1 032 | −34 | 992 749 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1357 | −2 208 | −73 | 5 697 463 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1357 | −292 | −10 | 993 781 | ||||
| 2020-11-06 | 2020-11-05 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,1473 | −7 816 | −259 | 5 689 647 | ||||
| 2020-11-06 | 2020-11-05 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,1473 | −1 032 | −34 | 992 749 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,1357 | −2 208 | −73 | 5 697 463 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,1357 | −292 | −10 | 993 781 | ||||
| 2020-11-04 | 2020-11-03 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 186 809 | |||||
| 2020-11-04 | 2020-11-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 31,9492 | −2 500 | −80 | 0 | ||||
| 2020-11-04 | 2020-11-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 2 500 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 6,42 | −3 000 | 238 616 | |||||
| 2020-11-03 | 2020-11-02 | 4 | Epstein David M. | BDTX | Common Stock | D | 31,8750 | −83 | −3 | 711 923 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Epstein David M. | BDTX | Common Stock | D | 31,1329 | −11 917 | −371 | 712 006 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Epstein David M. | BDTX | Common Stock | D | 6,4200 | 3 000 | 19 | 723 923 | ||||
| 2020-10-28 | 2020-10-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0325 | −707 | −23 | 5 699 671 | ||||
| 2020-10-28 | 2020-10-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0325 | −93 | −3 | 994 073 | ||||
| 2020-10-28 | 2020-10-26 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,3046 | −7 158 | −238 | 5 700 378 | ||||
| 2020-10-28 | 2020-10-26 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,3046 | −945 | −31 | 994 166 | ||||
| 2020-10-28 | 2020-10-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0325 | −707 | −23 | 5 699 671 | ||||
| 2020-10-28 | 2020-10-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0325 | −93 | −3 | 994 073 | ||||
| 2020-10-28 | 2020-10-26 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,3046 | −7 158 | −238 | 5 700 378 | ||||
| 2020-10-28 | 2020-10-26 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,3046 | −945 | −31 | 994 166 | ||||
| 2020-10-20 | 2020-10-19 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,4309 | −3 739 | −125 | 5 707 536 | ||||
| 2020-10-20 | 2020-10-19 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,4309 | −494 | −17 | 995 111 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,5728 | −7 697 | −258 | 5 711 275 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,5728 | −1 016 | −34 | 995 605 | ||||
| 2020-10-20 | 2020-10-15 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0343 | −2 473 | −82 | 5 718 972 | ||||
| 2020-10-20 | 2020-10-15 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0343 | −327 | −11 | 996 621 | ||||
| 2020-10-20 | 2020-10-19 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,4309 | −3 739 | −125 | 5 707 536 | ||||
| 2020-10-20 | 2020-10-19 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,4309 | −494 | −17 | 995 111 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,5728 | −7 697 | −258 | 5 711 275 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,5728 | −1 016 | −34 | 995 605 | ||||
| 2020-10-20 | 2020-10-15 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0343 | −2 473 | −82 | 5 718 972 | ||||
| 2020-10-20 | 2020-10-15 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0343 | −327 | −11 | 996 621 | ||||
| 2020-10-15 | 2020-10-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0906 | −4 859 | −161 | 5 721 445 | ||||
| 2020-10-15 | 2020-10-14 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0906 | −642 | −21 | 996 948 | ||||
| 2020-10-15 | 2020-10-13 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,3916 | −10 370 | −346 | 5 726 304 | ||||
| 2020-10-15 | 2020-10-13 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,3916 | −1 369 | −46 | 997 590 | ||||
| 2020-10-15 | 2020-10-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0906 | −4 859 | −161 | 5 721 445 | ||||
| 2020-10-15 | 2020-10-14 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0906 | −642 | −21 | 996 948 | ||||
| 2020-10-15 | 2020-10-13 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,3916 | −10 370 | −346 | 5 726 304 | ||||
| 2020-10-15 | 2020-10-13 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,3916 | −1 369 | −46 | 997 590 | ||||
| 2020-10-14 | 2020-10-12 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 194 420 | |||||
| 2020-10-14 | 2020-10-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 33,7541 | −295 | −10 | 3 000 | ||||
| 2020-10-14 | 2020-10-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 32,6126 | −3 783 | −123 | 3 295 | ||||
| 2020-10-14 | 2020-10-12 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 7 078 | ||||
| 2020-10-13 | 2020-10-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1075 | −353 | −12 | 5 736 674 | ||||
| 2020-10-13 | 2020-10-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,1075 | −47 | −2 | 998 959 | ||||
| 2020-10-13 | 2020-10-09 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,6665 | −3 357 | −113 | 5 737 027 | ||||
| 2020-10-13 | 2020-10-09 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,6665 | −443 | −15 | 999 006 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,6806 | −8 502 | −286 | 5 740 384 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,2469 | −7 774 | −258 | 5 748 886 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,6806 | −1 122 | −38 | 999 449 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,2469 | −1 027 | −34 | 1 000 571 | ||||
| 2020-10-13 | 2020-10-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,1075 | −353 | −12 | 5 736 674 | ||||
| 2020-10-13 | 2020-10-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,1075 | −47 | −2 | 998 959 | ||||
| 2020-10-13 | 2020-10-09 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,6665 | −3 357 | −113 | 5 737 027 | ||||
| 2020-10-13 | 2020-10-09 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,6665 | −443 | −15 | 999 006 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,6806 | −8 502 | −286 | 5 740 384 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,2469 | −7 774 | −258 | 5 748 886 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,6806 | −1 122 | −38 | 999 449 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,2469 | −1 027 | −34 | 1 000 571 | ||||
| 2020-10-09 | 2020-10-08 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 10,86 | −3 000 | 227 171 | |||||
| 2020-10-09 | 2020-10-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 33,5253 | −3 000 | −101 | 0 | ||||
| 2020-10-09 | 2020-10-08 | 4 | Leggett Thomas | BDTX | Common Stock | D | 10,8600 | 3 000 | 33 | 3 000 | ||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −4 131 | 0 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 3 098 | 4 131 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −57 424 | 486 597 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 033 | 1 033 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −192 576 | 1 631 864 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −588 | 0 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 588 | 588 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −593 | 0 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 593 | 593 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −39 608 | 1 001 598 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,5565 | −24 590 | −825 | 5 756 660 | ||||
| 2020-10-08 | 2020-10-07 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,5565 | −3 246 | −109 | 1 041 206 | ||||
| 2020-10-08 | 2020-10-06 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,2589 | −15 980 | −531 | 5 781 250 | ||||
| 2020-10-08 | 2020-10-06 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,2589 | −2 110 | −70 | 1 044 452 | ||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 449 | 10 178 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −4 131 | 0 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 3 098 | 4 131 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −57 424 | 486 597 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 033 | 1 033 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −192 576 | 1 631 864 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 22 | 8 729 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −588 | 0 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 588 | 588 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −593 | 0 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 593 | 593 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −39 608 | 1 001 598 | ||||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,5565 | −24 590 | −825 | 5 756 660 | ||||
| 2020-10-08 | 2020-10-07 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,5565 | −3 246 | −109 | 1 041 206 | ||||
| 2020-10-08 | 2020-10-06 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,2589 | −15 980 | −531 | 5 781 250 | ||||
| 2020-10-08 | 2020-10-06 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,2589 | −2 110 | −70 | 1 044 452 | ||||
| 2020-10-07 | 2020-10-05 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 189 309 | |||||
| 2020-10-07 | 2020-10-05 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 31,9850 | −227 | −7 | 0 | ||||
| 2020-10-07 | 2020-10-05 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 31,2042 | −2 273 | −71 | 227 | ||||
| 2020-10-07 | 2020-10-05 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 2 500 | ||||
| 2020-10-02 | 2020-10-01 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 6,42 | −3 000 | 241 616 | |||||
| 2020-10-02 | 2020-10-01 | 4 | Epstein David M. | BDTX | Common Stock | D | 30,3302 | −12 000 | −364 | 720 923 | ||||
| 2020-10-02 | 2020-10-01 | 4 | Epstein David M. | BDTX | Common Stock | D | 6,4200 | 3 000 | 19 | 732 923 | ||||
| 2020-10-01 | 2020-09-30 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Common Stock | D | 30,4570 | 5 000 | 152 | 5 000 | ||||
| 2020-09-29 | 2020-09-25 | 4 | INGRAM ROBERT ALEXANDER | BDTX | Stock Option (Right to Buy) | D | 29,65 | 29 842 | 29 842 | |||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 449 | 8 707 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −4 131 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 3 098 | 4 131 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −57 424 | 544 021 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 033 | 1 033 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −192 576 | 1 824 440 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 42 | 7 258 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −1 177 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 177 | 1 177 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −1 187 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 187 | 1 187 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −79 216 | 1 046 562 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 2 289 | 7 216 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −6 901 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 6 901 | 6 901 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −8 000 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 8 000 | 8 000 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −400 000 | 5 797 230 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −4 131 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 3 098 | 4 131 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −57 424 | 544 021 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 033 | 1 033 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −192 576 | 1 824 440 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −1 177 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 177 | 1 177 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −1 187 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 187 | 1 187 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −79 216 | 1 046 562 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −6 901 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 6 901 | 6 901 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −8 000 | 0 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 8 000 | 8 000 | ||||||
| 2020-09-21 | 2020-09-17 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | −400 000 | 5 797 230 | ||||||
| 2020-09-16 | 2020-09-14 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 3,20 | −4 078 | 198 498 | |||||
| 2020-09-16 | 2020-09-14 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 32,5499 | −207 | −7 | 3 000 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 31,4224 | −1 186 | −37 | 3 207 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 30,7554 | −2 685 | −83 | 4 393 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 3,2000 | 4 078 | 13 | 7 078 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 10,86 | −3 000 | 230 171 | |||||
| 2020-09-16 | 2020-09-14 | 4 | Leggett Thomas | BDTX | Common Stock | D | 31,0000 | −3 000 | −93 | 0 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Leggett Thomas | BDTX | Common Stock | D | 10,8600 | 3 000 | 33 | 3 000 | ||||
| 2020-09-10 | 2020-09-08 | 4 | HUMPHREY RACHEL | BDTX | Stock Option (Right to Buy) | D | 28,14 | 150 000 | 150 000 | |||||
| 2020-09-10 | 2020-09-08 | 4 | HUMPHREY RACHEL | BDTX | Common Stock | D | 10 000 | 10 000 | ||||||
| 2020-09-04 | 2020-09-03 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 10,86 | −2 500 | 191 809 | |||||
| 2020-09-04 | 2020-09-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 29,6338 | −2 358 | −70 | 0 | ||||
| 2020-09-04 | 2020-09-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 28,9500 | −142 | −4 | 2 358 | ||||
| 2020-09-04 | 2020-09-03 | 4 | Roberts Christopher D. | BDTX | Common Stock | D | 10,8600 | 2 500 | 27 | 2 500 | ||||
| 2020-08-20 | 2020-08-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 718 | 4 927 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −5 176 | 0 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 5 176 | 5 176 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −6 000 | 0 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 6 000 | 6 000 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −300 000 | 6 197 230 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −5 176 | 0 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 5 176 | 5 176 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −6 000 | 0 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 6 000 | 6 000 | ||||||
| 2020-08-20 | 2020-08-18 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | −300 000 | 6 197 230 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 718 | 3 209 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −5 176 | 0 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 5 176 | 5 176 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −6 000 | 0 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 6 000 | 6 000 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | −300 000 | 6 497 230 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −5 176 | 0 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 5 176 | 5 176 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −6 000 | 0 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 6 000 | 6 000 | ||||||
| 2020-08-14 | 2020-08-12 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | −300 000 | 6 497 230 | ||||||
| 2020-08-12 | 2020-08-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0813 | −6 692 | −221 | 6 797 230 | ||||
| 2020-08-12 | 2020-08-11 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0813 | −883 | −29 | 1 125 778 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 33,0382 | −5 492 | −181 | 6 803 922 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 33,0382 | −725 | −24 | 1 126 661 | ||||
| 2020-08-12 | 2020-08-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0813 | −6 692 | −221 | 6 797 230 | ||||
| 2020-08-12 | 2020-08-11 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0813 | −883 | −29 | 1 125 778 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0382 | −5 492 | −181 | 6 803 922 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 33,0382 | −725 | −24 | 1 126 661 | ||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 42 | 1 491 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −1 177 | 0 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 177 | 1 177 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −1 187 | 0 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 187 | 1 187 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −79 217 | 1 127 386 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | D | 1 449 | 1 449 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −4 131 | 0 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 3 098 | 4 131 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −57 424 | 601 445 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 033 | 1 033 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | −192 576 | 2 017 016 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −1 177 | 0 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 177 | 1 177 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −1 187 | 0 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 187 | 1 187 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −79 217 | 1 127 386 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −4 131 | 0 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 3 098 | 4 131 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −57 424 | 601 445 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 033 | 1 033 | ||||||
| 2020-07-29 | 2020-07-27 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | −192 576 | 2 017 016 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Behbahani Ali See Note 2 | BDTX | Series C Preferred Stock | I | −1 422 862 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Behbahani Ali See Note 2 | BDTX | Series B Preferred Stock | I | −6 565 290 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Behbahani Ali See Note 2 | BDTX | Common Stock | I | 19,0000 | 800 000 | 15 200 | 3 448 757 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Behbahani Ali See Note 2 | BDTX | Common Stock | I | 471 800 | 2 648 757 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Behbahani Ali See Note 2 | BDTX | Common Stock | I | 2 176 957 | 2 176 957 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Hatzis-Schoch Brent | BDTX | Common Stock | D | 19,0000 | 3 000 | 57 | 3 000 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Menzel Garry E | BDTX | Series A Preferred Stock | I | −156 297 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Menzel Garry E | BDTX | Common Stock | I | 51 825 | 51 825 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Epstein David M. | BDTX | Series B Preferred Stock | D | −13 136 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Epstein David M. | BDTX | Series A Preferred Stock | I | −69 636 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Epstein David M. | BDTX | Series A Preferred Stock | D | −732 560 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Epstein David M. | BDTX | Common Stock | D | 4 354 | 729 923 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Epstein David M. | BDTX | Common Stock | I | 23 090 | 23 090 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Epstein David M. | BDTX | Common Stock | D | 242 904 | 725 569 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Series C Preferred Stock | I | −92 063 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Series C Preferred Stock | I | −213 429 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Series C Preferred Stock | I | −548 224 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Series B Preferred Stock | I | −563 204 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Series B Preferred Stock | I | −492 643 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Series B Preferred Stock | I | −2 885 295 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 19,0000 | 136 539 | 2 594 | 353 814 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 19,0000 | 77 803 | 1 478 | 311 926 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 19,0000 | 785 658 | 14 928 | 1 924 164 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 30 526 | 217 275 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 70 770 | 234 123 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 181 783 | 1 138 506 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 186 749 | 186 749 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 163 353 | 163 353 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Shah Rajeev M. | BDTX | Common Stock | I | 956 723 | 956 723 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series C Preferred Stock | I | −1 055 960 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series C Preferred Stock | I | −314 873 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series C Preferred Stock | I | −1 370 833 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series C Preferred Stock | I | −2 444 382 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series B Preferred Stock | I | −1 517 940 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series B Preferred Stock | I | −452 630 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series B Preferred Stock | I | −1 970 572 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series A Preferred Stock | I | −3 851 526 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series A Preferred Stock | I | −1 148 474 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Series A Preferred Stock | I | −15 000 000 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 19,0000 | 396 081 | 7 526 | 1 206 603 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 19,0000 | 396 082 | 7 526 | 6 809 414 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 19,0000 | 23 560 | 448 | 658 869 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 19,0000 | 79 013 | 1 501 | 2 209 592 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 350 141 | 2 130 579 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 104 407 | 635 309 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 454 548 | 6 413 332 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 810 522 | 810 522 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 503 327 | 1 780 438 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 150 085 | 530 902 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 653 412 | 5 958 784 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 1 277 111 | 1 277 111 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 380 817 | 380 817 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 4 973 787 | 5 305 372 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series C Preferred Stock | I | −2 444 382 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series C Preferred Stock | I | −1 055 960 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series C Preferred Stock | I | −314 873 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series C Preferred Stock | D | −1 370 833 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series B Preferred Stock | I | −1 517 940 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series B Preferred Stock | I | −452 630 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series B Preferred Stock | D | −1 970 572 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series A Preferred Stock | I | −3 851 526 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series A Preferred Stock | I | −1 148 474 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Series A Preferred Stock | D | −15 000 000 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 19,0000 | 396 081 | 7 526 | 1 206 603 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 19,0000 | 396 082 | 7 526 | 6 809 414 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 19,0000 | 23 560 | 448 | 658 869 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 19,0000 | 79 013 | 1 501 | 2 209 592 | ||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 810 522 | 810 522 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 350 141 | 2 130 579 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 104 407 | 635 309 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 454 548 | 6 413 332 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 503 327 | 1 780 438 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 150 085 | 530 902 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 653 412 | 5 958 784 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 1 277 111 | 1 277 111 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | I | 380 817 | 380 817 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Versant Venture Capital VI, L.P. | BDTX | Common Stock | D | 4 973 787 | 5 305 372 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | BDTX | Series C Preferred Stock | D | −1 713 541 | 0 | ||||||
| 2020-02-05 | 2020-02-03 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | BDTX | Common Stock | D | 568 185 | 568 185 | ||||||
| 2020-02-03 | 2020-02-03 | 4 | Flynn James E Through Deerfield Partners, L.P. | BDTX | Series C Preferred Stock | I | −1 142 361 | 0 | ||||||
| 2020-02-03 | 2020-02-03 | 4 | Flynn James E Through Deerfield Partners, L.P. | BDTX | Common Stock | I | 19,0000 | 400 000 | 7 600 | 778 790 | ||||
| 2020-02-03 | 2020-02-03 | 4 | Flynn James E Through Deerfield Partners, L.P. | BDTX | Common Stock | I | 378 790 | 378 790 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Hatzis-Schoch Brent | BDTX | Stock Option (Right to Buy) | D | 19,00 | 78 751 | 78 751 | |||||
| 2020-01-31 | 2020-01-29 | 4 | Epstein David M. | BDTX | Stock Option (Right to Buy) | D | 19,00 | 278 532 | 278 532 | |||||
| 2020-01-31 | 2020-01-29 | 4 | Roberts Christopher D. | BDTX | Stock Option (Right to Buy) | D | 19,00 | 54 711 | 54 711 | |||||
| 2020-01-31 | 2020-01-29 | 4 | Leggett Thomas | BDTX | Stock Option (Right to Buy) | D | 19,00 | 55 540 | 55 540 | |||||
| 2020-01-29 | 3 | Versant Vantage I, L.P. | BDTX | Common Stock | D | 663 170 | ||||||||
| 2020-01-29 | 3 | Versant Vantage I, L.P. | BDTX | Common Stock | D | 663 170 | ||||||||
| 2020-01-29 | 3 | Versant Vantage I, L.P. | BDTX | Common Stock | D | 663 170 | ||||||||
| 2020-01-29 | 3 | Versant Vantage I, L.P. | BDTX | Common Stock | D | 663 170 | ||||||||
| 2020-01-29 | 3 | Versant Vantage I, L.P. | BDTX | Common Stock | D | 663 170 | ||||||||
| 2020-01-29 | 3 | Versant Vantage I, L.P. | BDTX | Common Stock | D | 663 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 829 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 829 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 741 300 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 741 300 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 829 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | D | 1 207 386 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 829 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 829 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 741 300 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 741 300 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | D | 1 207 386 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 741 300 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 741 300 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | I | 829 170 | ||||||||
| 2020-01-29 | 3 | Epstein David M. | BDTX | Common Stock | D | 1 207 386 | ||||||||
| 2020-01-29 | 3 | Mayweg Alexander | BDTX | Common Stock | D | 32 494 | ||||||||
| 2020-01-29 | 3 | Mayweg Alexander | BDTX | Common Stock | D | 32 494 | ||||||||
| 2020-01-29 | 3 | Mayweg Alexander | BDTX | Common Stock | D | 32 494 | ||||||||
| 2020-01-29 | 3 | Menzel Garry E | BDTX | Common Stock | D | 49 638 | ||||||||
| 2020-01-29 | 3 | Menzel Garry E | BDTX | Common Stock | D | 49 638 | ||||||||
| 2020-01-29 | 3 | Menzel Garry E | BDTX | Common Stock | D | 49 638 | ||||||||
| 2020-01-29 | 3 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 663 170 | ||||||||
| 2020-01-29 | 3 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 663 170 | ||||||||
| 2020-01-29 | 3 | Bolzon Bradley J PhD | BDTX | Common Stock | I | 663 170 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
